Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Liver Diseases

  Free Subscription

Articles published in Eur Radiol

Retrieve available abstracts of 317 articles:
HTML format

Single Articles

    April 2024
  1. RATA M, De Paepe KN, Orton MR, Castagnoli F, et al
    Evaluation of simultaneous multi-slice acquisition with advanced processing for free-breathing diffusion-weighted imaging in patients with liver metastasis.
    Eur Radiol. 2024;34:2457-2467.
    PubMed     Abstract available

  2. CARUSO D, De Santis D, Del Gaudio A, Guido G, et al
    Low-dose liver CT: image quality and diagnostic accuracy of deep learning image reconstruction algorithm.
    Eur Radiol. 2024;34:2384-2393.
    PubMed     Abstract available

  3. NAKAZAWA Y, Okada M, Hyodo T, Tago K, et al
    Comparison between CT volumetry, technetium(99m) galactosyl-serum-albumin scintigraphy, and gadoxetic-acid-enhanced MRI to estimate the liver fibrosis stage in preoperative patients.
    Eur Radiol. 2024;34:2212-2222.
    PubMed     Abstract available

    March 2024
  4. GROSS M, Haider SP, Ze'evi T, Huber S, et al
    Automated graded prognostic assessment for patients with hepatocellular carcinoma using machine learning.
    Eur Radiol. 2024 Mar 27. doi: 10.1007/s00330-024-10624.
    PubMed     Abstract available

  5. KIM TH, Woo S, Lee DH, Do RK, et al
    MRI imaging features for predicting macrotrabecular-massive subtype hepatocellular carcinoma: a systematic review and meta-analysis.
    Eur Radiol. 2024 Mar 20. doi: 10.1007/s00330-024-10671.
    PubMed     Abstract available

  6. BOUATTOUR M, Vilgrain V, Sepulveda A
    ESR Bridges: imaging and treatment of hepatocellular carcinoma-a multidisciplinary view.
    Eur Radiol. 2024 Mar 15. doi: 10.1007/s00330-023-10579.

  7. BYENFELDT M, Kihlberg J, Nasr P, Gronlund C, et al
    Altered probe pressure and body position increase diagnostic accuracy for men and women in detecting hepatic steatosis using quantitative ultrasound.
    Eur Radiol. 2024 Mar 8. doi: 10.1007/s00330-024-10655.
    PubMed     Abstract available

  8. ZHANG A, Meng X, Yao Y, Zhou X, et al
    Head to head comparison of (68)Ga-DOTA-FAPI-04 vs (18)F-FDG PET/CT in the evaluation of primary extrapulmonary tumors in the chest.
    Eur Radiol. 2024;34:1960-1970.
    PubMed     Abstract available

    February 2024
  9. YOO J, Joo I, Jeon SK, Park J, et al
    Utilizing fully-automated 3D organ segmentation for hepatic steatosis assessment with CT attenuation-based parameters.
    Eur Radiol. 2024 Feb 23. doi: 10.1007/s00330-024-10660.
    PubMed     Abstract available

  10. CANNELLA R, Zins M, Brancatelli G
    ESR Essentials: diagnosis of hepatocellular carcinoma-practice recommendations by ESGAR.
    Eur Radiol. 2024 Feb 21. doi: 10.1007/s00330-024-10606.
    PubMed     Abstract available

  11. VARIN E, Beunon P, N'Kontchou G, Petit A, et al
    Incidence and clinical impact of bile ducts changes after multibipolar radiofrequency ablation for hepatocellular carcinoma.
    Eur Radiol. 2024 Feb 9. doi: 10.1007/s00330-024-10617.
    PubMed     Abstract available

  12. KIM GH, Kim JH, Shim JH, Kim SY, et al
    Chemoembolization versus radiofrequency ablation for single small (
    Eur Radiol. 2024 Feb 8. doi: 10.1007/s00330-024-10634.
    PubMed     Abstract available

  13. ZHANG Y, Hu X, Chang J, Li W, et al
    A new method to estimate the histological stage of primary biliary cholangitis.
    Eur Radiol. 2024;34:770-779.
    PubMed     Abstract available

  14. ZHANG Y, Fan X, Song B, Liu Y, et al
    Noninvasive prediction of insufficient biochemical response after ursodeoxycholic acid treatment in patients with primary biliary cholangitis based on pretreatment nonenhanced MRI.
    Eur Radiol. 2024;34:1268-1279.
    PubMed     Abstract available

    January 2024
  15. LIU W, Wei R, Chen J, Li Y, et al
    Prognosis prediction and risk stratification of transarterial chemoembolization or intraarterial chemotherapy for unresectable hepatocellular carcinoma based on machine learning.
    Eur Radiol. 2024 Jan 30. doi: 10.1007/s00330-024-10581.
    PubMed     Abstract available

  16. XU Y, Yang Y, Ouyang J, Zhou Y, et al
    Publisher Correction: Reclassification of therapeutic response of unresectable hepatocellular carcinoma to anti-angiogenic therapy and immunotherapy using alpha RECIST.
    Eur Radiol. 2024 Jan 29. doi: 10.1007/s00330-023-10575.

  17. AUER TA
    Diffusion-weighted imaging for the detection of liver metastases in the preoperative evaluation of pancreatic cancer - are we really at the end of the road?
    Eur Radiol. 2024;34:103-105.

  18. ALTMAYER S, Armelin LM, Pereira JS, Carvalho LV, et al
    MRI with DWI improves detection of liver metastasis and selection of surgical candidates with pancreatic cancer: a systematic review and meta-analysis.
    Eur Radiol. 2024;34:106-114.
    PubMed     Abstract available

  19. QIN S, Chen Y, Wang Y, Li F, et al
    Contrast-enhanced ultrasound with microbubbles containing sulfur hexafluoride and perfluorobutane with Kupffer phase for the detection of colorectal liver metastases.
    Eur Radiol. 2024;34:622-631.
    PubMed     Abstract available

  20. CUI E
    Reducing radiation dose in routine CT scans: an AI-driven approach with deep learning-based dual-energy CT reconstruction.
    Eur Radiol. 2024;34:26-27.

  21. LYU P, Li Z, Chen Y, Wang H, et al
    Deep learning reconstruction CT for liver metastases: low-dose dual-energy vs standard-dose single-energy.
    Eur Radiol. 2024;34:28-38.
    PubMed     Abstract available

  22. MIN JH, Lee MW, Rhim H, Han S, et al
    LI-RADS category is associated with treatment outcomes of small single HCC: surgical resection vs. radiofrequency ablation.
    Eur Radiol. 2024;34:525-537.
    PubMed     Abstract available

    December 2023
  23. TAOULI B, Ba-Ssalamah A, Chapiro J, Chhatwal J, et al
    Consensus report from the 10th Global Forum for Liver Magnetic Resonance Imaging: developments in HCC management.
    Eur Radiol. 2023;33:9152-9166.
    PubMed     Abstract available

  24. JOSKOWICZ L, Szeskin A, Rochman S, Dodi A, et al
    Follow-up of liver metastases: a comparison of deep learning and RECIST 1.1.
    Eur Radiol. 2023;33:9320-9327.
    PubMed     Abstract available

  25. TAOULI B, Ba-Ssalamah A, Chapiro J, Chhatwal J, et al
    Consensus report from the 10th global forum for liver magnetic resonance imaging: multidisciplinary team discussion.
    Eur Radiol. 2023;33:9167-9181.
    PubMed     Abstract available

  26. HUANG H, Li CQ, He DN, Ruan SM, et al
    Surveillance for malignant progression of LI-RADS version 2017 category 3/4 nodules using contrast-enhanced ultrasound.
    Eur Radiol. 2023;33:9336-9346.
    PubMed     Abstract available

  27. ORCEL T, Chau HT, Turlin B, Chaigneau J, et al
    Evaluation of proton density fat fraction (PDFF) obtained from a vendor-neutral MRI sequence and MRQuantif software.
    Eur Radiol. 2023;33:8999-9009.
    PubMed     Abstract available

  28. JIN ZC, Zhong BY, Chen JJ, Zhu HD, et al
    Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study.
    Eur Radiol. 2023;33:8669-8681.
    PubMed     Abstract available

  29. ZHANG K, Zhang L, Li WC, Xie SS, et al
    Radiomics nomogram for the prediction of microvascular invasion of HCC and patients' benefit from postoperative adjuvant TACE: a multi-center study.
    Eur Radiol. 2023;33:8936-8947.
    PubMed     Abstract available

    November 2023
  30. DUCATEL A, Trillaud H, Reizine E, Vilgrain V, et al
    Sonic hedgehog hepatocellular adenoma: magnetic resonance imaging features and correlation with histology.
    Eur Radiol. 2023 Nov 28. doi: 10.1007/s00330-023-10344.
    PubMed     Abstract available

  31. YAN H, Xiang Z, Zhao C, Luo S, et al
    6-mm shunt transjugular intrahepatic portosystemic shunt in patients with severe liver atrophy and variceal bleeding.
    Eur Radiol. 2023 Nov 25. doi: 10.1007/s00330-023-10346.
    PubMed     Abstract available

  32. REN J, Lu Q, Fei X, Dong Y, et al
    Assessment of arterial-phase hyperenhancement and late-phase washout of hepatocellular carcinoma-a meta-analysis of contrast-enhanced ultrasound (CEUS) with SonoVue(R) and Sonazoid(R).
    Eur Radiol. 2023 Nov 22. doi: 10.1007/s00330-023-10371.
    PubMed     Abstract available

  33. DEMONDION E, Ernst O, Louvet A, Robert B, et al
    Hepatic fat quantification in dual-layer computed tomography using a three-material decomposition algorithm.
    Eur Radiol. 2023 Nov 13. doi: 10.1007/s00330-023-10382.
    PubMed     Abstract available

  34. BASTATI N, Perkonigg M, Sobotka D, Poetter-Lang S, et al
    Correlation of histologic, imaging, and artificial intelligence features in NAFLD patients, derived from Gd-EOB-DTPA-enhanced MRI: a proof-of-concept study.
    Eur Radiol. 2023;33:7729-7743.
    PubMed     Abstract available

  35. CANNELLA R, Santinha J, Beaufrere A, Ronot M, et al
    Performances and variability of CT radiomics for the prediction of microvascular invasion and survival in patients with HCC: a matter of chance or standardisation?
    Eur Radiol. 2023;33:7618-7628.
    PubMed     Abstract available

  36. CHEN X, Hu P, Yu H, Tan H, et al
    Head-to-head intra-individual comparison of total-body 2-[(18)F]FDG PET/CT and digital PET/CT in patients with malignant tumor: how sensitive could it be?
    Eur Radiol. 2023;33:7890-7898.
    PubMed     Abstract available

    Diffuse liver disease: the new horizon of multiparametric ultrasound.
    Eur Radiol. 2023;33:7629-7630.

  38. LEBLANC M, Kang J, Costa AF
    Can we rely on contrast-enhanced CT to identify pancreatic ductal adenocarcinoma? A population-based study in sensitivity and factors associated with false negatives.
    Eur Radiol. 2023;33:7656-7664.
    PubMed     Abstract available

  39. PALMISANO A, Gnasso C, Cereda A, Vignale D, et al
    Chest CT opportunistic biomarkers for phenotyping high-risk COVID-19 patients: a retrospective multicentre study.
    Eur Radiol. 2023;33:7756-7768.
    PubMed     Abstract available

    October 2023
  40. YU H, Zhao F, Men X, Zhu H, et al
    Microwave ablation versus laparoscopic resection for hepatocellular carcinoma in patients with clinically significant portal hypertension: a propensity score-matched study of postoperative liver decompensation.
    Eur Radiol. 2023 Oct 25. doi: 10.1007/s00330-023-10268.
    PubMed     Abstract available

  41. HWANG SH, Rhee H
    Pushing the limit of hepatocellular carcinoma diagnosis: diagnosis of subcentimetre HCC using gadoxetic acid-enhanced MRI and alpha-fetoprotein.
    Eur Radiol. 2023 Oct 23. doi: 10.1007/s00330-023-10376.

  42. JIANG H, Qin Y, Wei H, Zheng T, et al
    Prognostic MRI features to predict postresection survivals for very early to intermediate stage hepatocellular carcinoma.
    Eur Radiol. 2023 Oct 23. doi: 10.1007/s00330-023-10279.
    PubMed     Abstract available

  43. ZHANG Y, Chen J, Yang C, Dai Y, et al
    Preoperative prediction of microvascular invasion in hepatocellular carcinoma using diffusion-weighted imaging-based habitat imaging.
    Eur Radiol. 2023 Oct 19. doi: 10.1007/s00330-023-10339.
    PubMed     Abstract available

  44. HEO S, Kang HJ, Choi SH, Kim S, et al
    Proliferative hepatocellular carcinomas in cirrhosis: patient outcomes of LI-RADS category 4/5 and category M.
    Eur Radiol. 2023 Oct 18. doi: 10.1007/s00330-023-10305.
    PubMed     Abstract available

  45. DELAGNES A, Roux M, Vilgrain V, Guiu B, et al
    Fat-containing hepatocellular carcinoma in patients with cirrhosis: proposal of a diagnostic modification regarding enhancement characteristics.
    Eur Radiol. 2023 Oct 11. doi: 10.1007/s00330-023-10236.
    PubMed     Abstract available

  46. YU Q, Ungchusri E, Pillai A, Liao CY, et al
    Selective internal radiation therapy using yttrium-90 microspheres for treatment of localized and locally advanced intrahepatic cholangiocarcinoma.
    Eur Radiol. 2023 Oct 9. doi: 10.1007/s00330-023-10203.
    PubMed     Abstract available

  47. HUANG P, Wu F, Hou K, Zhou C, et al
    Diagnostic algorithm for subcentimeter hepatocellular carcinoma using alpha-fetoprotein and imaging features on gadoxetic acid-enhanced MRI.
    Eur Radiol. 2023 Oct 4. doi: 10.1007/s00330-023-10214.
    PubMed     Abstract available

  48. HERNANDO D, van der Heijden RA, Reeder SB
    A better understanding of liver T1.
    Eur Radiol. 2023;33:6841-6843.

  49. HIGASHI M, Tanabe M, Yamane M, Keerthivasan MB, et al
    Impact of fat on the apparent T1 value of the liver: assessment by water-only derived T1 mapping.
    Eur Radiol. 2023;33:6844-6851.
    PubMed     Abstract available

  50. AMORIM J
    HCC screening with non-contrast MRI and alpha-fetoprotein: combining a new player with an old friend.
    Eur Radiol. 2023;33:6927-6928.

  51. WARY P, Hossu G, Ambarki K, Nickel D, et al
    Deep learning HASTE sequence compared with T2-weighted BLADE sequence for liver MRI at 3 Tesla: a qualitative and quantitative prospective study.
    Eur Radiol. 2023;33:6817-6827.
    PubMed     Abstract available

  52. RADIYA K, Joakimsen HL, Mikalsen KO, Aahlin EK, et al
    Performance and clinical applicability of machine learning in liver computed tomography imaging: a systematic review.
    Eur Radiol. 2023;33:6689-6717.
    PubMed     Abstract available

  53. AUER TA, Halskov S, Fehrenbach U, Nevermann NF, et al
    Gd-EOB MRI for HCC subtype differentiation in a western population according to the 5(th) edition of the World Health Organization classification.
    Eur Radiol. 2023;33:6902-6915.
    PubMed     Abstract available

  54. VOLPE S, Mastroleo F, Krengli M, Jereczek-Fossa BA, et al
    Quo vadis Radiomics? Bibliometric analysis of 10-year Radiomics journey.
    Eur Radiol. 2023;33:6736-6745.
    PubMed     Abstract available

  55. PARK HL, Boo SH, Park SY, Moon SW, et al
    Prognostic value of TLR from FDG PET/CT in patients with margin-negative stage IB and IIA non-small cell lung cancer.
    Eur Radiol. 2023;33:7274-7283.
    PubMed     Abstract available

    September 2023
  56. ZAFAR S, Elbanna KY, Todd AWM, Guimaraes L, et al
    Can absolute arterial phase hyperenhancement improve sensitivity of detection of hepatocellular carcinoma in indeterminate nodules on CT?
    Eur Radiol. 2023 Sep 30. doi: 10.1007/s00330-023-10237.
    PubMed     Abstract available

  57. XU Y, Yang Y, Ouyang J, Zhou Y, et al
    Reclassification of therapeutic response of unresectable hepatocellular carcinoma to anti-angiogenic therapy and immunotherapy using alpha RECIST.
    Eur Radiol. 2023 Sep 23. doi: 10.1007/s00330-023-10222.
    PubMed     Abstract available

  58. YOON S, Shim YS, Park SH, Sung J, et al
    Hepatobiliary phase imaging in cirrhotic patients using compressed sensing and controlled aliasing in parallel imaging results in higher acceleration.
    Eur Radiol. 2023 Sep 21. doi: 10.1007/s00330-023-10226.
    PubMed     Abstract available

  59. DING F, Huang M, Ren P, Zhang J, et al
    Quantitative information from gadobenate dimeglumine-enhanced MRI can predict proliferative subtype of solitary hepatocellular carcinoma: a multicenter retrospective study.
    Eur Radiol. 2023 Sep 11. doi: 10.1007/s00330-023-10227.
    PubMed     Abstract available

  60. NACHIT M, Dioguardi Burgio M, Abyzov A, Garteiser P, et al
    Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease is associated with heterogeneous pattern of fat infiltration in skeletal muscles.
    Eur Radiol. 2023 Sep 2. doi: 10.1007/s00330-023-10131.
    PubMed     Abstract available

  61. METENS T
    Can quantified diffusion-weighted imaging predict histopathological features of liver tumors?
    Eur Radiol. 2023;33:5953-5954.

  62. MARTH AA, Auer TA, Walter-Rittel TC, Nevermann N, et al
    Gd-EOB-DTPA-MRCP to localize bile leakage after liver trauma and surgery: impact on treatment and outcome.
    Eur Radiol. 2023;33:5933-5942.
    PubMed     Abstract available

  63. CHENG Y, Zhang XD, Chen C, He LF, et al
    Dynamic evolution of brain structural patterns in liver transplantation recipients: a longitudinal study based on 3D convolutional neuronal network model.
    Eur Radiol. 2023;33:6134-6144.
    PubMed     Abstract available

  64. LEE S, Kim YY, Shin J, Roh YH, et al
    Liver Imaging Reporting and Data System version 2018 category 5 for diagnosing hepatocellular carcinoma: an updated meta-analysis.
    Eur Radiol. 2023 Sep 1. doi: 10.1007/s00330-023-10134.
    PubMed     Abstract available

  65. LEE H, Chang W, Kim HY, Sung P, et al
    Improving radiomics reproducibility using deep learning-based image conversion of CT reconstruction algorithms in hepatocellular carcinoma patients.
    Eur Radiol. 2023 Sep 1. doi: 10.1007/s00330-023-10135.
    PubMed     Abstract available

    August 2023
  66. HAN K, Kim JH, Kim GH, Kim JH, et al
    Radiofrequency ablation of subcapsular versus nonsubcapsular hepatocellular carcinomas
    Eur Radiol. 2023 Aug 30. doi: 10.1007/s00330-023-10165.
    PubMed     Abstract available

  67. WU J, Zhao Q, Wang Y, Xiao F, et al
    Feeding artery: a valuable feature for differentiation of regenerative nodule, dysplastic nodules and small hepatocellular carcinoma in CEUS LI-RADS.
    Eur Radiol. 2023 Aug 17. doi: 10.1007/s00330-023-10006.
    PubMed     Abstract available

  68. JEONG B, Choi SJ, Choi SH, Jang HJ, et al
    LI-RADS threshold growth based on tumor growth rate can improve the diagnosis of hepatocellular carcinoma
    Eur Radiol. 2023 Aug 17. doi: 10.1007/s00330-023-10092.
    PubMed     Abstract available

  69. DUAN X, Li H, Chen P, Sun T, et al
    Transcatheter arterial chemoembolization using CalliSpheres beads loaded with arsenic trioxide for unresectable large or huge hepatocellular carcinoma: a prospective study.
    Eur Radiol. 2023 Aug 15. doi: 10.1007/s00330-023-10097.
    PubMed     Abstract available

  70. LONG H, Zhou X, Zhang X, Ye J, et al
    3D fusion is superior to 2D point-to-point contrast-enhanced US to evaluate the ablative margin after RFA for hepatocellular carcinoma.
    Eur Radiol. 2023 Aug 12. doi: 10.1007/s00330-023-10023.
    PubMed     Abstract available

  71. SHENG R, Zhang Y, Wang H, Zhang W, et al
    A multi-center diagnostic system for intrahepatic mass-forming cholangiocarcinoma based on preoperative MRI and clinical features.
    Eur Radiol. 2023 Aug 8. doi: 10.1007/s00330-023-10002.
    PubMed     Abstract available

  72. STOCKER D, King MJ, Homsi ME, Gnerre J, et al
    Early post-treatment MRI predicts long-term hepatocellular carcinoma response to radiation segmentectomy.
    Eur Radiol. 2023 Aug 4. doi: 10.1007/s00330-023-10045.
    PubMed     Abstract available

  73. OH NE, Choi SH, Kim S, Lee H, et al
    Suboptimal performance of LI-RADS v2018 on gadoxetic acid-enhanced MRI for detecting hepatocellular carcinoma in liver transplant candidates.
    Eur Radiol. 2023 Aug 3. doi: 10.1007/s00330-023-10014.
    PubMed     Abstract available

  74. PAN J, Song M, Yang L, Zhao Y, et al
    The role of enhancing capsule and modified capsule appearances in LI-RADS for diagnosing HCC
    Eur Radiol. 2023;33:5801-5811.
    PubMed     Abstract available

  75. YANG Y, Liu J, Sun C, Shi Y, et al
    Nonalcoholic fatty liver disease (NAFLD) detection and deep learning in a Chinese community-based population.
    Eur Radiol. 2023;33:5894-5906.
    PubMed     Abstract available

  76. ACOSTA IZQUIERDO L, Rai A, Saprungruang A, Chavhan GB, et al
    Assessment of liver fibrosis using a 3-dimensional high-resolution late gadolinium enhancement sequence in children and adolescents with Fontan circulation.
    Eur Radiol. 2023;33:5446-5454.
    PubMed     Abstract available

    July 2023
  77. CHA DI, Kang TW, Jeong WK, Kim JM, et al
    Preoperative assessment of microvascular invasion risk using gadoxetate-enhanced MRI for predicting outcomes after liver transplantation for single hepatocellular carcinoma within the Milan criteria.
    Eur Radiol. 2023 Jul 28. doi: 10.1007/s00330-023-09936.
    PubMed     Abstract available

  78. XU Z, An C, Shi F, Ren H, et al
    Automatic prediction of hepatic arterial infusion chemotherapy response in advanced hepatocellular carcinoma with deep learning radiomic nomogram.
    Eur Radiol. 2023 Jul 27. doi: 10.1007/s00330-023-09953.
    PubMed     Abstract available

  79. MINAMIGUCHI K, Irizato M, Uchiyama T, Taiji R, et al
    Hepatobiliary-phase gadolinium ethoxybenzyl-diethylenetriaminepentaacetic acid MRI for pretreatment prediction of efficacy-to-standard-therapies based on Barcelona Clinic Liver Cancer algorithm: an up-to-date review.
    Eur Radiol. 2023 Jul 20. doi: 10.1007/s00330-023-09950.
    PubMed     Abstract available

  80. POETTER-LANG S, Messner A, Bastati N, Ringe KI, et al
    Diagnosis of functional strictures in patients with primary sclerosing cholangitis using hepatobiliary contrast-enhanced MRI: a proof-of-concept study.
    Eur Radiol. 2023 Jul 20. doi: 10.1007/s00330-023-09915.
    PubMed     Abstract available

  81. KIM SH, Kim JH, Kim GH, Kim JH, et al
    Intermediate-stage (BCLC stage B) infiltrative hepatocellular carcinoma: safety and efficacy of chemoembolization.
    Eur Radiol. 2023 Jul 19. doi: 10.1007/s00330-023-09961.
    PubMed     Abstract available

  82. GIRARDET R, Dubois M, Manasseh G, Jreige M, et al
    The combination of non-contrast abbreviated MRI and alpha foetoprotein has high performance for hepatocellular carcinoma screening.
    Eur Radiol. 2023 Jul 18. doi: 10.1007/s00330-023-09906.
    PubMed     Abstract available

  83. HUANG H, Cheng MQ, He DN, Xian MF, et al
    US LI-RADS in surveillance for recurrent hepatocellular carcinoma after curative treatment.
    Eur Radiol. 2023 Jul 18. doi: 10.1007/s00330-023-09903.
    PubMed     Abstract available

  84. GAO Y, Yu Q, Li X, Xia C, et al
    An imaging-based machine learning model outperforms clinical risk scores for prognosis of cirrhotic variceal bleeding.
    Eur Radiol. 2023 Jul 15. doi: 10.1007/s00330-023-09938.
    PubMed     Abstract available

  85. CHENG S, Hu G, Jin Z, Wang Z, et al
    CT-based radiomics nomogram for prediction of survival after transarterial chemoembolization with drug-eluting beads in patients with hepatocellular carcinoma and portal vein tumor thrombus.
    Eur Radiol. 2023 Jul 12. doi: 10.1007/s00330-023-09830.
    PubMed     Abstract available

  86. LIU Q, Shi S, Liu S, Xu X, et al
    The added value of [(68)Ga]Ga-DOTA-FAPI-04 PET/CT in pancreatic cancer: a comparison to [(18)F]F-FDG.
    Eur Radiol. 2023;33:5007-5016.
    PubMed     Abstract available

  87. XU Y, Zhou C, He X, Song R, et al
    Deep learning-assisted LI-RADS grading and distinguishing hepatocellular carcinoma (HCC) from non-HCC based on multiphase CT: a two-center study.
    Eur Radiol. 2023 Jul 1. doi: 10.1007/s00330-023-09857.
    PubMed     Abstract available

  88. SHEN K, Mo W, Wang X, Shi D, et al
    A convenient scoring system to distinguish intrahepatic mass-forming cholangiocarcinoma from solitary colorectal liver metastasis based on magnetic resonance imaging features.
    Eur Radiol. 2023 Jul 1. doi: 10.1007/s00330-023-09873.
    PubMed     Abstract available

    June 2023
    Non-invasive prediction of microvascular invasion in patients with hepatocellular carcinoma: is there any added value in combining imaging features and radiomics?
    Eur Radiol. 2023 Jun 30. doi: 10.1007/s00330-023-09792.

  90. KUPCZYK PA, Kurt D, Endler C, Luetkens JA, et al
    MRI proton density fat fraction for estimation of tumor grade in steatotic hepatocellular carcinoma.
    Eur Radiol. 2023 Jun 27. doi: 10.1007/s00330-023-09864.
    PubMed     Abstract available

  91. SUROV A, Eger KI, Potratz J, Gottschling S, et al
    Apparent diffusion coefficient correlates with different histopathological features in several intrahepatic tumors.
    Eur Radiol. 2023 Jun 22. doi: 10.1007/s00330-023-09788.
    PubMed     Abstract available

  92. ZHENG R, Zhang X, Liu B, Zhang Y, et al
    Comparison of non-radiomics imaging features and radiomics models based on contrast-enhanced ultrasound and Gd-EOB-DTPA-enhanced MRI for predicting microvascular invasion in hepatocellular carcinoma within 5 cm.
    Eur Radiol. 2023 Jun 20. doi: 10.1007/s00330-023-09789.
    PubMed     Abstract available

  93. LONG H, Peng C, Ding H, Zheng Y, et al
    Predicting symptomatic post-hepatectomy liver failure in patients with hepatocellular carcinoma: development and validation of a preoperative nomogram.
    Eur Radiol. 2023 Jun 14. doi: 10.1007/s00330-023-09803.
    PubMed     Abstract available

  94. NADJIRI J, Waggershauser T, Muhlmann M, Ehmer U, et al
    Transjugular intrahepatic portosystemic shunt creation (TIPS) in the angio-CT-a hybrid intervention with image fusion.
    Eur Radiol. 2023 Jun 7. doi: 10.1007/s00330-023-09793.
    PubMed     Abstract available

  95. REN Z, Wen D, Xue R, Li S, et al
    Nonalcoholic fatty liver disease is associated with myocardial ischemia by CT myocardial perfusion imaging, independent of clinical and coronary CT angiography characteristics.
    Eur Radiol. 2023;33:3857-3866.
    PubMed     Abstract available

  96. KIM JW, Lee CH, Kim KA, Lee J, et al
    Abbreviated MRI with second shot arterial phase for HCC evaluation: modified version of LI-RADS and recall reduction strategy.
    Eur Radiol. 2023;33:4401-4411.
    PubMed     Abstract available

  97. HUANG Z, Zhu RH, Xin JY, Li KY, et al
    HCC treated with immune checkpoint inhibitors: a hyper-enhanced rim on Sonazoid-CEUS Kupffer phase images is a predictor of tumor response.
    Eur Radiol. 2023;33:4389-4400.
    PubMed     Abstract available

  98. PARK SH, Yoon JH, Park JY, Shim YS, et al
    Performance of free-breathing dynamic T1-weighted sequences in patients at risk of developing motion artifacts undergoing gadoxetic acid-enhanced liver MRI.
    Eur Radiol. 2023;33:4378-4388.
    PubMed     Abstract available

    May 2023
  99. HWANG SM, Cho KY
    Noninvasive assessment of paediatric hepatic steatosis by using attenuation imaging.
    Eur Radiol. 2023 May 17:1-13. doi: 10.1007/s00330-023-09731.
    PubMed     Abstract available

  100. WEI H, Fu F, Jiang H, Wu Y, et al
    Development and validation of the OSASH score to predict overall survival of hepatocellular carcinoma after surgical resection: a dual-institutional study.
    Eur Radiol. 2023 May 16. doi: 10.1007/s00330-023-09725.
    PubMed     Abstract available

  101. KUBLER J, Krumm P, Martirosian P, Winkelmann MT, et al
    Improved visualization of hepatic tumors in magnetic resonance-guided thermoablation using T1-inversion-recovery imaging with variable inversion time.
    Eur Radiol. 2023 May 3. doi: 10.1007/s00330-023-09696.
    PubMed     Abstract available

  102. DERBEL H, Krichen M, Chalaye J, Saccenti L, et al
    Accuracy and reproducibility of a cone beam CT-based virtual parenchymal perfusion algorithm in the prediction of SPECT/CT anatomical and volumetric results during the planification of radioembolization for HCC.
    Eur Radiol. 2023;33:3510-3520.
    PubMed     Abstract available

  103. AAPKES SE, Barten TRM, Coudyzer W, Drenth JPH, et al
    Validation of a semi-automatic method to measure total liver volumes in polycystic liver disease on computed tomography - high speed and accuracy.
    Eur Radiol. 2023;33:3222-3231.
    PubMed     Abstract available

  104. LIU G, Chen S, Hu Y, Cao S, et al
    Respiratory-gated PET imaging with reduced acquisition time for suspect malignancies: the first experience in application of total-body PET/CT.
    Eur Radiol. 2023;33:3366-3376.
    PubMed     Abstract available

    April 2023
  105. YAO J, Li K, Yang H, Lu S, et al
    Analysis of Sonazoid contrast-enhanced ultrasound for predicting the risk of microvascular invasion in hepatocellular carcinoma: a prospective multicenter study.
    Eur Radiol. 2023 Apr 28. doi: 10.1007/s00330-023-09656.
    PubMed     Abstract available

  106. SAID D, Carbonell G, Stocker D, Hectors S, et al
    Semiautomated segmentation of hepatocellular carcinoma tumors with MRI using convolutional neural networks.
    Eur Radiol. 2023 Apr 18. doi: 10.1007/s00330-023-09613.
    PubMed     Abstract available

  107. JANG HJ, Choi SH, Choi SJ, Choi WM, et al
    LI-RADS version 2018 for hepatocellular carcinoma < 1.0 cm on gadoxetate disodium-enhanced magnetic resonance imaging.
    Eur Radiol. 2023 Apr 5. doi: 10.1007/s00330-023-09554.
    PubMed     Abstract available

  108. PAN YJ, Liu W, Qiu QX, Miao SL, et al
    Prognostic value of LI-RADS category on MRI in patients with primary hepatic lymphoepithelioma-like carcinoma.
    Eur Radiol. 2023 Apr 4. doi: 10.1007/s00330-023-09598.
    PubMed     Abstract available

  109. NIE P, Zhang J, Miao W, Duan S, et al
    Incremental value of radiomics-based heterogeneity to the existing risk criteria in predicting recurrence of hepatocellular carcinoma after liver transplantation.
    Eur Radiol. 2023 Apr 4. doi: 10.1007/s00330-023-09591.
    PubMed     Abstract available

  110. CHOI JY, Lee SS, Kim NY, Park HJ, et al
    The effect of hepatic steatosis on liver volume determined by proton density fat fraction and deep learning-measured liver volume.
    Eur Radiol. 2023 Apr 4. doi: 10.1007/s00330-023-09603.
    PubMed     Abstract available

  111. FAN W, Zhu B, Yue S, Zheng X, et al
    Identifying optimal candidates for post-TIPS patients with HCC undergoing TACE: a multicenter observational study.
    Eur Radiol. 2023;33:2809-2820.
    PubMed     Abstract available

  112. MIRAGLIA R, Maruzzelli L, Mamone G, Petridis I, et al
    Right vs left portal branch puncture in TIPS creation with controlled expansion covered stent: comparison of hemodynamic and clinical outcomes.
    Eur Radiol. 2023;33:2647-2654.
    PubMed     Abstract available

  113. LI C, Tian Y, Chen J, Jiang Y, et al
    Usefulness of [(68)Ga]FAPI-04 and [(18)F]FDG PET/CT for the detection of primary tumour and metastatic lesions in gastrointestinal carcinoma: a comparative study.
    Eur Radiol. 2023;33:2779-2791.
    PubMed     Abstract available

    March 2023
  114. KANG HJ, Lee JM, Ahn C, Bae JS, et al
    Low dose of contrast agent and low radiation liver computed tomography with deep-learning-based contrast boosting model in participants at high-risk for hepatocellular carcinoma: prospective, randomized, double-blind study.
    Eur Radiol. 2023 Mar 18. doi: 10.1007/s00330-023-09520.
    PubMed     Abstract available

  115. PARK SH, Kim B, Kim S, Park S, et al
    Estimating postsurgical outcomes of patients with a single hepatocellular carcinoma using gadoxetic acid-enhanced MRI: risk scoring system development and validation.
    Eur Radiol. 2023 Mar 18. doi: 10.1007/s00330-023-09539.
    PubMed     Abstract available

  116. CAI S, Lin N, Yang Y, Ma W, et al
    The value of contrast-enhanced portal vein imaging at the hepatobiliary phase obtained with gadobenate dimeglumine for predicting decompensation and transplant-free survival in chronic liver disease.
    Eur Radiol. 2023 Mar 10. doi: 10.1007/s00330-023-09489.
    PubMed     Abstract available

  117. LI Q, Zhang T, Che F, Yao S, et al
    Intravoxel incoherent motion diffusion weighted imaging for preoperative evaluation of liver regeneration after hepatectomy in hepatocellular carcinoma.
    Eur Radiol. 2023 Mar 9. doi: 10.1007/s00330-023-09496.
    PubMed     Abstract available

  118. WANG L, Feng B, Li D, Liang M, et al
    Risk stratification of solitary hepatocellular carcinoma
    Eur Radiol. 2023 Mar 8. doi: 10.1007/s00330-023-09484.
    PubMed     Abstract available

  119. ZHAO QX, He XL, Wang K, Cheng ZG, et al
    Deep learning model based on contrast-enhanced ultrasound for predicting early recurrence after thermal ablation of colorectal cancer liver metastasis.
    Eur Radiol. 2023;33:1895-1905.
    PubMed     Abstract available

  120. TADA A, Nagai T, Kato Y, Omote K, et al
    Liver stiffness assessed by magnetic resonance elastography predicts clinical outcomes in patients with heart failure and without chronic liver disease.
    Eur Radiol. 2023;33:2062-2074.
    PubMed     Abstract available

  121. LYU P, Liu N, Harrawood B, Solomon J, et al
    Is it possible to use low-dose deep learning reconstruction for the detection of liver metastases on CT routinely?
    Eur Radiol. 2023;33:1629-1640.
    PubMed     Abstract available

  122. WANG G, Kang B, Cui J, Deng Y, et al
    Two nomograms based on radiomics models using triphasic CT for differentiation of adrenal lipid-poor benign lesions and metastases in a cancer population: an exploratory study.
    Eur Radiol. 2023;33:1873-1883.
    PubMed     Abstract available

  123. LEE HS, Kwon HW, Lim SB, Kim JC, et al
    FDG metabolic parameter-based models for predicting recurrence after upfront surgery in synchronous colorectal cancer liver metastasis.
    Eur Radiol. 2023;33:1746-1756.
    PubMed     Abstract available

    February 2023
  124. YAN M, Zhang X, Zhang B, Geng Z, et al
    Deep learning nomogram based on Gd-EOB-DTPA MRI for predicting early recurrence in hepatocellular carcinoma after hepatectomy.
    Eur Radiol. 2023 Feb 14. doi: 10.1007/s00330-023-09419.
    PubMed     Abstract available

  125. YUAN E, Chen Y, Song B
    Quality of radiomics for predicting microvascular invasion in hepatocellular carcinoma: a systematic review.
    Eur Radiol. 2023 Feb 7. doi: 10.1007/s00330-023-09414.
    PubMed     Abstract available

  126. LAMPICHLER K, Semmler G, Woran K, Simbrunner B, et al
    Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder.
    Eur Radiol. 2023;33:1422-1432.
    PubMed     Abstract available

  127. LIU Y, Zhou B, Tang W, Xu D, et al
    Preoperative transarterial chemoembolization with drug-eluting beads (DEB-TACE) in patients undergoing conversional hepatectomy: a propensity-score matching analysis.
    Eur Radiol. 2023;33:1022-1030.
    PubMed     Abstract available

  128. AARTS BM, Gomez FM, Lopez-Yurda M, Bevers RFM, et al
    Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysis.
    Eur Radiol. 2023;33:1040-1049.
    PubMed     Abstract available

  129. MULE S, Serhal A, Pregliasco AG, Nguyen J, et al
    MRI features associated with HCC histologic subtypes: a western American and European bicenter study.
    Eur Radiol. 2023;33:1342-1352.
    PubMed     Abstract available

  130. MULLER L, Mahringer-Kunz A, Auer TA, Fehrenbach U, et al
    Low bone mineral density is a prognostic factor for elderly patients with HCC undergoing TACE: results from a multicenter study.
    Eur Radiol. 2023;33:1031-1039.
    PubMed     Abstract available

    January 2023
  131. WU F, Sun H, Zhou C, Huang P, et al
    Prognostic factors for long-term outcome in bifocal hepatocellular carcinoma after resection.
    Eur Radiol. 2023 Jan 26. doi: 10.1007/s00330-023-09398.
    PubMed     Abstract available

  132. EIRAS-ARAUJO AL, Parente DB, da Silva AC, da Motta Rezende GF, et al
    Relative enhancement index can be used to quantify liver function in cirrhotic patients that undergo gadoxetic acid-enhanced MRI.
    Eur Radiol. 2023 Jan 18. doi: 10.1007/s00330-023-09402.
    PubMed     Abstract available

  133. WU T, Yang D, Wee A, Wang Y, et al
    Identification of MRI features associated with injury type, severity, and prognosis in drug-induced liver injury.
    Eur Radiol. 2023;33:666-677.
    PubMed     Abstract available

  134. POETTER-LANG S, Dovjak GO, Messner A, Ambros R, et al
    Influence of dilution on arterial-phase artifacts and signal intensity on gadoxetic acid-enhanced liver MRI.
    Eur Radiol. 2023;33:523-534.
    PubMed     Abstract available

  135. RENDELL VR, Winslow ER, Colgan TJ, Kovacs SK, et al
    Radiologic-pathologic correlation of lesions in resected liver specimens with an ex vivo MRI-compatible localization device.
    Eur Radiol. 2023;33:535-544.
    PubMed     Abstract available

  136. ZHENG W, Guo W, Xiong M, Chen X, et al
    Clinic-radiological features and radiomics signatures based on Gd-BOPTA-enhanced MRI for predicting advanced liver fibrosis.
    Eur Radiol. 2023;33:633-644.
    PubMed     Abstract available

  137. SEO N, Joo DJ, Park MS, Kim SS, et al
    Optimal imaging criteria and modality to determine Milan criteria for the prediction of post-transplant HCC recurrence after locoregional treatment.
    Eur Radiol. 2023;33:501-511.
    PubMed     Abstract available

    December 2022
  138. GOU X, Jia W, He C, Yuan X, et al
    Hepatic hydrothorax does not increase the risk of death after transjugular intrahepatic portosystemic shunt in cirrhosis patients.
    Eur Radiol. 2022 Dec 28. doi: 10.1007/s00330-022-09357.
    PubMed     Abstract available

  139. BAE JS, Lee JM, Kim SW, Park S, et al
    Low-contrast-dose liver CT using low monoenergetic images with deep learning-based denoising for assessing hepatocellular carcinoma: a randomized controlled noninferiority trial.
    Eur Radiol. 2022 Dec 28. doi: 10.1007/s00330-022-09298.
    PubMed     Abstract available

  140. LUO M, Liu X, Yong J, Ou B, et al
    Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma based on B-Mode US and CEUS.
    Eur Radiol. 2022 Dec 9. doi: 10.1007/s00330-022-09322.
    PubMed     Abstract available

  141. CHU HH, Gwon DI, Kim GH, Kim JH, et al
    Balloon-occluded transarterial chemoembolization versus conventional transarterial chemoembolization for the treatment of single hepatocellular carcinoma: a propensity score matching analysis.
    Eur Radiol. 2022 Dec 6. doi: 10.1007/s00330-022-09284.
    PubMed     Abstract available

  142. HUANG P, Zhou C, Wu F, Xiao Y, et al
    An improved diagnostic algorithm for subcentimeter hepatocellular carcinoma on gadoxetic acid-enhanced MRI.
    Eur Radiol. 2022 Dec 6. doi: 10.1007/s00330-022-09282.
    PubMed     Abstract available

  143. YAGHMAI V
    CT-derived extracellular volume to predict post-hepatectomy liver failure: a simple approach to a very complex problem.
    Eur Radiol. 2022;32:8527-8528.

  144. YU MM, Tang XL, Zhao X, Chen YY, et al
    Plaque progression at coronary CT angiography links non-alcoholic fatty liver disease and cardiovascular events: a prospective single-center study.
    Eur Radiol. 2022;32:8111-8121.
    PubMed     Abstract available

  145. DING WZ, Liu S, Liu F, Cheng Z, et al
    Are all local tumour progressions of HCC related to thermal ablation? A study of the causes and classification of local tumour progression.
    Eur Radiol. 2022;32:8518-8526.
    PubMed     Abstract available

    November 2022
  146. ZHANG L, Li M, Zhu J, Zhang Y, et al
    The value of quantitative MR elastography-based stiffness for assessing the microvascular invasion grade in hepatocellular carcinoma.
    Eur Radiol. 2022 Nov 26. doi: 10.1007/s00330-022-09290.
    PubMed     Abstract available

  147. MARUZZELLI L, D'Amico M, Tuzzolino F, Petridis I, et al
    Clinical outcomes of transjugular intrahepatic portosystemic shunt with PTFE-covered stents after liver transplantation and technical results in split and whole liver graft recipients.
    Eur Radiol. 2022 Nov 23. doi: 10.1007/s00330-022-09259.
    PubMed     Abstract available

  148. CAI Q, Mao Y, Dai S, Gao F, et al
    The growth pattern of liver metastases on MRI predicts early recurrence in patients with colorectal cancer: a multicenter study.
    Eur Radiol. 2022;32:7872-7882.
    PubMed     Abstract available

    September 2022
  149. LIU K, Zheng H, Sui X, Liu B, et al
    Microwave ablation versus surgical resection for subcapsular hepatocellular carcinoma: a propensity score-matched study of long-term therapeutic outcomes.
    Eur Radiol. 2022 Sep 17. pii: 10.1007/s00330-022-09135.
    PubMed     Abstract available

  150. XIAO Y, Zheng X, Zhou C, Huang P, et al
    Combined hepatocellular carcinoma-cholangiocarcinoma with a predominant HCC component: better survival and MRI-based prediction.
    Eur Radiol. 2022 Sep 16. pii: 10.1007/s00330-022-09131.
    PubMed     Abstract available

  151. CHERNYAK V, Tang A, Do RKG, Kamaya A, et al
    Liver imaging: it is time to adopt standardized terminology.
    Eur Radiol. 2022;32:6291-6301.
    PubMed     Abstract available

  152. JOO I, Morrow KW, Raman SS, McWilliams JP, et al
    CT-monitored minimal ablative margin control in single-session microwave ablation of liver tumors: an effective strategy for local tumor control.
    Eur Radiol. 2022;32:6327-6335.
    PubMed     Abstract available

  153. VIETTI VIOLI N, Gnerre J, Law A, Hectors S, et al
    Assessment of HCC response to Yttrium-90 radioembolization with gadoxetate disodium MRI: correlation with histopathology.
    Eur Radiol. 2022;32:6493-6503.
    PubMed     Abstract available

  154. WANG H, Guo Y, Yan B, Zhang Q, et al
    Development and validation of a prediction model based on clinical and CT features for invasiveness of K. pneumoniae liver abscess.
    Eur Radiol. 2022;32:6397-6406.
    PubMed     Abstract available

  155. TAN BG, Tang Z, Ou J, Zhou HY, et al
    A novel model based on liver/spleen volumes and portal vein diameter on MRI to predict variceal bleeding in HBV cirrhosis.
    Eur Radiol. 2022 Sep 1. pii: 10.1007/s00330-022-09107.
    PubMed     Abstract available

    August 2022
  156. ZHANG X, Luo Y, Tsauo J, Zhao H, et al
    Transradial versus transfemoral access without closure device for transarterial chemoembolization in patients with hepatocellular carcinoma: a randomized trial.
    Eur Radiol. 2022 Aug 26. pii: 10.1007/s00330-022-09038.
    PubMed     Abstract available

  157. CHA H, Choi JY, Park YN, Han K, et al
    Comparison of imaging findings of macrotrabecular-massive hepatocellular carcinoma using CT and gadoxetic acid-enhanced MRI.
    Eur Radiol. 2022 Aug 24. pii: 10.1007/s00330-022-09105.
    PubMed     Abstract available

  158. XU Y, Zhang Y, Zheng CZ, Li C, et al
    Thermal ablation versus hepatic resection for colorectal cancer with synchronous liver metastases: a propensity score matching study.
    Eur Radiol. 2022 Aug 24. pii: 10.1007/s00330-022-09080.
    PubMed     Abstract available

  159. SALEH GA, Elmokadem AH, Razek AA, El-Morsy A, et al
    Utility of diffusion tensor imaging in differentiating benign from malignant hepatic focal lesions.
    Eur Radiol. 2022 Aug 18. pii: 10.1007/s00330-022-09091.
    PubMed     Abstract available

  160. CHEN G, Jiao D, Peng S, Chen X, et al
    Peritumoral abnormalities on dynamic-enhanced CT after brachytherapy for hepatic malignancies: local progression or benign changes?
    Eur Radiol. 2022 Aug 18. pii: 10.1007/s00330-022-09074.
    PubMed     Abstract available

  161. ZHOU C, Lu X, Wang Y, Qian X, et al
    Histopathological components correlated with MRI features and prognosis in combined hepatocellular carcinoma-cholangiocarcinoma.
    Eur Radiol. 2022 Aug 17. pii: 10.1007/s00330-022-09065.
    PubMed     Abstract available

  162. NALLET C, Pazart L, Cochet C, Vidal C, et al
    Prenatal quantification of human foetal lung and liver elasticities between 24 and 39 weeks of gestation using 2D shear wave elastography.
    Eur Radiol. 2022;32:5559-5567.
    PubMed     Abstract available

  163. HONG S, Choi SH, Hong SB, Kim SY, et al
    Clinical usefulness of multiple arterial-phase images in gadoxetate disodium-enhanced magnetic resonance imaging: a systematic review and meta-analysis.
    Eur Radiol. 2022;32:5413-5423.
    PubMed     Abstract available

    July 2022
  164. KIM TH, Lee JM, Lee DH, Joo I, et al
    Can "no-touch" radiofrequency ablation for hepatocellular carcinoma improve local tumor control? Systematic review and meta-analysis.
    Eur Radiol. 2022 Jul 30. pii: 10.1007/s00330-022-08991.
    PubMed     Abstract available

  165. OCAL O, Zech CJ, Fabritius MP, Loewe C, et al
    Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progression.
    Eur Radiol. 2022 Jul 26. pii: 10.1007/s00330-022-09000.
    PubMed     Abstract available

  166. HUANG JX, Shi CG, Xu YF, Fu J, et al
    The benefit of contrast-enhanced ultrasound in biopsies for focal liver lesions: a retrospective study of 820 cases.
    Eur Radiol. 2022 Jul 26. pii: 10.1007/s00330-022-08988.
    PubMed     Abstract available

  167. CHEN BB, Liang PC, Shih TT, Liu TH, et al
    Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma.
    Eur Radiol. 2022 Jul 21. pii: 10.1007/s00330-022-08980.
    PubMed     Abstract available

  168. KIM YY, Lee S, Shin J, Son WJ, et al
    Diagnostic performance of CT versus MRI Liver Imaging Reporting and Data System category 5 for hepatocellular carcinoma: a systematic review and meta-analysis of comparative studies.
    Eur Radiol. 2022 Jul 18. pii: 10.1007/s00330-022-08985.
    PubMed     Abstract available

  169. CHOI SJ, Choi SH, Lee DY, Lee JS, et al
    Diagnostic value of [(68) Ga]Ga-DOTA-labeled-somatostatin analogue PET/MRI for detecting liver metastasis in patients with neuroendocrine tumors: a systematic review and meta-analysis.
    Eur Radiol. 2022;32:4628-4637.
    PubMed     Abstract available

  170. ZHU HD, Li X, Ji JS, Huang M, et al
    TACE with dicycloplatin in patients with unresectable hepatocellular carcinoma: a multicenter randomized phase II trial.
    Eur Radiol. 2022 Jul 1. pii: 10.1007/s00330-022-08848.
    PubMed     Abstract available

    June 2022
  171. WANG MQ, Duan F, Guan Y, Yuan B, et al
    Long-term outcomes of transarterial embolization with lipiodol-bleomycin emulsion plus polyvinyl alcohol particles versus the particles alone for large symptomatic focal nodular hyperplasia: a propensity score-matched analysis.
    Eur Radiol. 2022 Jun 28. pii: 10.1007/s00330-022-08972.
    PubMed     Abstract available

  172. DIMOV IP, Tous C, Li N, Barat M, et al
    Assessment of hepatic arterial hemodynamics with 4D flow MRI: in vitro analysis of motion and spatial resolution related error and in vivo feasibility study in 20 volunteers.
    Eur Radiol. 2022 Jun 22. pii: 10.1007/s00330-022-08890.
    PubMed     Abstract available

  173. KENNEDY P, Stocker D, Carbonell G, Said D, et al
    MR elastography outperforms shear wave elastography for the diagnosis of clinically significant portal hypertension.
    Eur Radiol. 2022 Jun 21. pii: 10.1007/s00330-022-08935.
    PubMed     Abstract available

  174. LIU B, Zeng Q, Huang J, Zhang J, et al
    IVIM using convolutional neural networks predicts microvascular invasion in HCC.
    Eur Radiol. 2022 Jun 17. pii: 10.1007/s00330-022-08927.
    PubMed     Abstract available

  175. HWANG JA, Jeong WK, Kang HJ, Lee ES, et al
    Perfluorobutane-enhanced ultrasonography with a Kupffer phase: improved diagnostic sensitivity for hepatocellular carcinoma.
    Eur Radiol. 2022 Jun 16. pii: 10.1007/s00330-022-08900.
    PubMed     Abstract available

  176. JIAO CY, Zhang H, Ji GW, Xu Q, et al
    CT-based clinico-radiological nomograms for prognosis prediction in patients with intrahepatic mass-forming cholangiocarcinoma: a multi-institutional study.
    Eur Radiol. 2022 Jun 16. pii: 10.1007/s00330-022-08914.
    PubMed     Abstract available

  177. PENG Y, Shen H, Tang H, Huang Y, et al
    Nomogram based on CT-derived extracellular volume for the prediction of post-hepatectomy liver failure in patients with resectable hepatocellular carcinoma.
    Eur Radiol. 2022 Jun 9. pii: 10.1007/s00330-022-08917.
    PubMed     Abstract available

  178. DE COBELLI F, Calandri M, Della Corte A, Sirovich R, et al
    Multi-institutional analysis of outcomes for thermosphere microwave ablation treatment of colorectal liver metastases: the SMAC study.
    Eur Radiol. 2022;32:4147-4159.
    PubMed     Abstract available

  179. ZHANG K, Xie SS, Li WC, Ye ZX, et al
    Prediction of microvascular invasion in HCC by a scoring model combining Gd-EOB-DTPA MRI and biochemical indicators.
    Eur Radiol. 2022;32:4186-4197.
    PubMed     Abstract available

    May 2022
  180. HUANG Z, Zhou P, Li S, Li K, et al
    Evaluation of contrast-enhanced ultrasound LI-RADS version 2017: application on 271 liver nodules in individuals with non-alcoholic steatohepatitis.
    Eur Radiol. 2022 May 31. pii: 10.1007/s00330-022-08872.
    PubMed     Abstract available

  181. MENG D, Liang C, Zheng Y, Wang X, et al
    The value of gadobenate dimeglumine-enhanced biliary imaging from the hepatobiliary phase for predicting post-hepatectomy liver failure in HCC patients.
    Eur Radiol. 2022 May 31. pii: 10.1007/s00330-022-08874.
    PubMed     Abstract available

  182. TAGO K, Tsukada J, Sudo N, Shibutani K, et al
    Comparison between CT volumetry and extracellular volume fraction using liver dynamic CT for the predictive ability of liver fibrosis in patients with hepatocellular carcinoma.
    Eur Radiol. 2022 May 20. pii: 10.1007/s00330-022-08852.
    PubMed     Abstract available

  183. PAN J, Li W, Gu L, Liu C, et al
    Performance of adding hepatobiliary phase image in magnetic resonance imaging for detection of hepatocellular carcinoma: a meta-analysis.
    Eur Radiol. 2022 May 17. pii: 10.1007/s00330-022-08826.
    PubMed     Abstract available

  184. WEI H, Jiang H, Qin Y, Wu Y, et al
    Comparison of a preoperative MR-based recurrence risk score versus the postoperative score and four clinical staging systems in hepatocellular carcinoma: a retrospective cohort study.
    Eur Radiol. 2022 May 13. pii: 10.1007/s00330-022-08811.
    PubMed     Abstract available

  185. HEO S, Kim DW, Choi SH, Kim SW, et al
    Diagnostic performance of liver fibrosis assessment by quantification of liver surface nodularity on computed tomography and magnetic resonance imaging: systematic review and meta-analysis.
    Eur Radiol. 2022;32:3377-3387.
    PubMed     Abstract available

  186. SHIN J, Lee S, Hwang JA, Lee JE, et al
    MRI-diagnosis of category LR-M observations in the Liver Imaging Reporting and Data System v2018: a systematic review and meta-analysis.
    Eur Radiol. 2022;32:3319-3326.
    PubMed     Abstract available

  187. TANG A, Dzyubak B, Yin M, Schlein A, et al
    MR elastography in nonalcoholic fatty liver disease: inter-center and inter-analysis-method measurement reproducibility and accuracy at 3T.
    Eur Radiol. 2022;32:2937-2948.
    PubMed     Abstract available

  188. PARK S, Yoon JH, Joo I, Yu MH, et al
    Image quality in liver CT: low-dose deep learning vs standard-dose model-based iterative reconstructions.
    Eur Radiol. 2022;32:2865-2874.
    PubMed     Abstract available

  189. GHADIMI M, Birnbaum J, Kamel IR, Sirlin CB, et al
    What proportion of LI-RADS 5 observations reported in clinical practice do not meet LI-RADS 5 criteria?
    Eur Radiol. 2022;32:3327-3333.
    PubMed     Abstract available

    April 2022
  190. QIU Z, Wang G, Yan H, Qi H, et al
    TIPS plus sequential systemic therapy of advanced HCC patients with tumour thrombus-related symptomatic portal hypertension.
    Eur Radiol. 2022 Apr 20. pii: 10.1007/s00330-022-08705.
    PubMed     Abstract available

  191. ZHANG W, Wang J, Linghu R, Chen X, et al
    Correction to: Comparison between spleen and liver stiffness measurements by sound touch elastography for diagnosing cirrhosis at different aminotransferase levels: a prospective multicenter study.
    Eur Radiol. 2022 Apr 12. pii: 10.1007/s00330-022-08727.

  192. MULLER L, Kloeckner R, Mahringer-Kunz A, Stoehr F, et al
    Fully automated AI-based splenic segmentation for predicting survival and estimating the risk of hepatic decompensation in TACE patients with HCC.
    Eur Radiol. 2022 Apr 8. pii: 10.1007/s00330-022-08737.
    PubMed     Abstract available

  193. WANG X, Tan Y, Liu D, Shen H, et al
    Chemotherapy-associated steatohepatitis was concomitant with epicardial adipose tissue volume increasing in breast cancer patients who received neoadjuvant chemotherapy.
    Eur Radiol. 2022 Apr 8. pii: 10.1007/s00330-022-08581.
    PubMed     Abstract available

  194. XIA D, Wang Q, Bai W, Wang E, et al
    Optimal time point of response assessment for predicting survival is associated with tumor burden in hepatocellular carcinoma receiving repeated transarterial chemoembolization.
    Eur Radiol. 2022 Apr 6. pii: 10.1007/s00330-022-08716.
    PubMed     Abstract available

  195. LEE T, Lee JM, Yoon JH, Joo I, et al
    Deep learning-based image reconstruction of 40-keV virtual monoenergetic images of dual-energy CT for the assessment of hypoenhancing hepatic metastasis.
    Eur Radiol. 2022 Apr 5. pii: 10.1007/s00330-022-08728.
    PubMed     Abstract available

  196. ZHANG YN, Fowler KJ, Boehringer AS, Montes V, et al
    Comparative diagnostic performance of ultrasound shear wave elastography and magnetic resonance elastography for classifying fibrosis stage in adults with biopsy-proven nonalcoholic fatty liver disease.
    Eur Radiol. 2022;32:2457-2469.
    PubMed     Abstract available

  197. DOEMEL LA, Santana JG, Savic LJ, Gaupp FML, et al
    Comparison of metabolic and immunologic responses to transarterial chemoembolization with different chemoembolic regimens in a rabbit VX2 liver tumor model.
    Eur Radiol. 2022;32:2437-2447.
    PubMed     Abstract available

  198. BENOIT C, Rodrigues A, Calderaro J, Charpy C, et al
    Autofluorescence imaging within the liver: a promising tool for the detection and characterization of primary liver tumors.
    Eur Radiol. 2022;32:2481-2491.
    PubMed     Abstract available

    March 2022
  199. YOUN SY, Kim B, Kim DH, Choi HJ, et al
    Liver Imaging-Reporting and Data System treatment response algorithm predicts postsurgical recurrence in locoregional therapy-treated hepatocellular carcinoma.
    Eur Radiol. 2022 Mar 29. pii: 10.1007/s00330-022-08720.
    PubMed     Abstract available

  200. WANG Y, Zhu GQ, Zhou CW, Li N, et al
    Risk stratification of LI-RADS M and LI-RADS 4/5 combined hepatocellular cholangiocarcinoma: prognostic values of MR imaging features and clinicopathological factors.
    Eur Radiol. 2022 Mar 22. pii: 10.1007/s00330-022-08691.
    PubMed     Abstract available

  201. SHENG R, Huang X, Jin K, Gao S, et al
    Contrast-enhanced MRI could predict response of systemic therapy in advanced intrahepatic cholangiocarcinoma.
    Eur Radiol. 2022 Mar 17. pii: 10.1007/s00330-022-08679.
    PubMed     Abstract available

  202. LUO N, Huang X, Ji Y, Jin G, et al
    A functional liver imaging score for preoperative prediction of liver failure after hepatocellular carcinoma resection.
    Eur Radiol. 2022 Mar 16. pii: 10.1007/s00330-022-08656.
    PubMed     Abstract available

  203. PAN J, Tao Y, Chi X, Yang L, et al
    Do transition and hepatobiliary phase hypointensity improve LI-RADS categorization as an alternative washout: a systematic review and meta-analysis.
    Eur Radiol. 2022 Mar 10. pii: 10.1007/s00330-022-08665.
    PubMed     Abstract available

  204. YOON JK, Choi JY, Rhee H, Park YN, et al
    MRI features of histologic subtypes of hepatocellular carcinoma: correlation with histologic, genetic, and molecular biologic classification.
    Eur Radiol. 2022 Mar 8. pii: 10.1007/s00330-022-08643.
    PubMed     Abstract available

  205. KONG J, Gao R, Wu S, Shi Y, et al
    Correction to: Safety and efficacy of microwave versus radiofrequency ablation for large hepatic hemangioma: a multicenter retrospective study with propensity score matching.
    Eur Radiol. 2022 Mar 3. pii: 10.1007/s00330-022-08634.

  206. COSTANTINO A, Piagnani A, Nandi N, Sciola V, et al
    Reproducibility and diagnostic accuracy of pocket-sized ultrasound devices in ruling out compensated cirrhosis of mixed etiology.
    Eur Radiol. 2022 Mar 3. pii: 10.1007/s00330-022-08572.
    PubMed     Abstract available

  207. YAN Y, Xing X, Wang X, Yang L, et al
    Liver stiffness by two-dimensional shear wave elastography for screening high-risk varices in patients with compensated advanced chronic liver disease.
    Eur Radiol. 2022;32:2078-2088.
    PubMed     Abstract available

  208. BOS D, Yu S, Luong J, Chu P, et al
    Diagnostic reference levels and median doses for common clinical indications of CT: findings from an international registry.
    Eur Radiol. 2022;32:1971-1982.
    PubMed     Abstract available

  209. WANG Q, Wang A, Sparrelid E, Zhang J, et al
    Predictive value of gadoxetic acid-enhanced MRI for posthepatectomy liver failure: a systematic review.
    Eur Radiol. 2022;32:1792-1803.
    PubMed     Abstract available

  210. CANNELLA R, Vernuccio F, Antonucci M, Gagliano DS, et al
    LI-RADS ancillary features favoring benignity: is there a role in LR-5 observations?
    Eur Radiol. 2022;32:1804-1812.
    PubMed     Abstract available

  211. DIOGUARDI BURGIO M, Sartoris R, Beaufrere A, Gregory J, et al
    Liver surface nodularity on non-contrast MRI identifies advanced fibrosis in patients with NAFLD.
    Eur Radiol. 2022;32:1781-1791.
    PubMed     Abstract available

  212. SCHATTENBERG JM, Emrich T
    Refining imaging tools to detect advanced fibrosis: could liver surface nodularity address an unmet need in the NAFLD epidemic?
    Eur Radiol. 2022;32:1757-1759.

  213. LUDEMANN W, Kahn J, Pustelnik D, Hardt J, et al
    Yttrium-90 radioembolization for unresectable hepatocellular carcinoma: predictive modeling strategies to anticipate tumor response and improve patient selection.
    Eur Radiol. 2022 Mar 1. pii: 10.1007/s00330-022-08585.
    PubMed     Abstract available

    February 2022
  214. ZHANG W, Wang J, Linghu R, Chen X, et al
    Comparison between spleen and liver stiffness measurements by sound touch elastography for diagnosing cirrhosis at different aminotransferase levels: a prospective multicenter study.
    Eur Radiol. 2022 Feb 28. pii: 10.1007/s00330-022-08569.
    PubMed     Abstract available

  215. PARK HJ, Lee TY, Kim SY, Kim MJ, et al
    Hypervascular transformation of hepatobiliary phase hypointense nodules without arterial phase hyperenhancement on gadoxetic acid-enhanced MRI: long-term follow-up in a surveillance cohort.
    Eur Radiol. 2022 Feb 28. pii: 10.1007/s00330-022-08623.
    PubMed     Abstract available

  216. LIU Y, Tan HY, Zhang XG, Zhen YH, et al
    Prediction of high-risk esophageal varices in patients with chronic liver disease with point and 2D shear wave elastography: a systematic review and meta-analysis.
    Eur Radiol. 2022 Feb 15. pii: 10.1007/s00330-022-08601.
    PubMed     Abstract available

  217. LI M, Yin Z, Hu B, Guo N, et al
    MR Elastography-Based Shear Strain Mapping for Assessment of Microvascular Invasion in Hepatocellular Carcinoma.
    Eur Radiol. 2022 Feb 11. pii: 10.1007/s00330-022-08578.
    PubMed     Abstract available

  218. SERBANESCU-KELE APOR DE ZALAN , Ruiter SJS, van den Berg AP, Pennings JP, et al
    Outcomes after primary and repeat thermal ablation of hepatocellular carcinoma with or without liver transplantation.
    Eur Radiol. 2022 Feb 8. pii: 10.1007/s00330-021-08515.
    PubMed     Abstract available

  219. ZHOU Y, Zhou G, Zhang J, Xu C, et al
    DCE-MRI based radiomics nomogram for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma.
    Eur Radiol. 2022 Feb 7. pii: 10.1007/s00330-022-08548.
    PubMed     Abstract available

  220. XIONG J, Luo J, Bian J, Wu J, et al
    Overall diagnostic accuracy of different MR imaging sequences for detection of dysplastic nodules: a systematic review and meta-analysis.
    Eur Radiol. 2022;32:1285-1296.
    PubMed     Abstract available

  221. LI X, Qi Z, Du H, Geng Z, et al
    Deep convolutional neural network for preoperative prediction of microvascular invasion and clinical outcomes in patients with HCCs.
    Eur Radiol. 2022;32:771-782.
    PubMed     Abstract available

  222. MIN JH, Kim JM, Kim YK, Kim H, et al
    A modified LI-RADS: targetoid tumors with enhancing capsule can be diagnosed as HCC instead of LR-M lesions.
    Eur Radiol. 2022;32:912-922.
    PubMed     Abstract available

  223. SUN C, Zhang X, Chen X, Zhu T, et al
    Single-direction diffusion-weighted imaging may be a simple complementary sequence for evaluating fetal corpus callosum.
    Eur Radiol. 2022;32:1135-1143.
    PubMed     Abstract available

    January 2022
  224. ZHENG H, Liu K, Yang Y, Liu B, et al
    Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study.
    Eur Radiol. 2022 Jan 29. pii: 10.1007/s00330-022-08537.
    PubMed     Abstract available

  225. KONG J, Gao R, Wu S, Shi Y, et al
    Safety and efficacy of microwave versus radiofrequency ablation for large hepatic hemangioma: a multicenter retrospective study with propensity score matching.
    Eur Radiol. 2022 Jan 29. pii: 10.1007/s00330-021-08425.
    PubMed     Abstract available

  226. KELAHAN LC, Kim D, Soliman M, Avery RJ, et al
    Role of hepatic metastatic lesion size on inter-reader reproducibility of CT-based radiomics features.
    Eur Radiol. 2022 Jan 26. pii: 10.1007/s00330-021-08526.
    PubMed     Abstract available

  227. DONG SY, Wang WT, Chen XS, Yang YT, et al
    Microvascular invasion of small hepatocellular carcinoma can be preoperatively predicted by the 3D quantification of MRI.
    Eur Radiol. 2022 Jan 25. pii: 10.1007/s00330-021-08495.
    PubMed     Abstract available

  228. YOUNG S, Chen T, Flanagan S, Golzarian J, et al
    Realized tumor to normal ratios in hepatocellular carcinoma patients undergoing transarterial radioembolization: a retrospective evaluation.
    Eur Radiol. 2022 Jan 15. pii: 10.1007/s00330-021-08501.
    PubMed     Abstract available

  229. SUN SH, Eche T, Dorczynski C, Otal P, et al
    Predicting death or recurrence of portal hypertension symptoms after TIPS procedures.
    Eur Radiol. 2022 Jan 11. pii: 10.1007/s00330-021-08437.
    PubMed     Abstract available

  230. LIU C, Shen Z, Ma H, Wang X, et al
    Gd-BOPTA-enhanced hepatobiliary phase MR imaging can predict the prognosis of patients with acute-on-chronic liver failure.
    Eur Radiol. 2022 Jan 6. pii: 10.1007/s00330-021-08440.
    PubMed     Abstract available

  231. WACKENTHALER A, Moliere S, Artzner T, Michard B, et al
    Pre-operative CT scan helps predict outcome after liver transplantation for acute-on-chronic grade 3 liver failure.
    Eur Radiol. 2022;32:12-21.
    PubMed     Abstract available

  232. JEON SK, Joo I, Bae JS, Park SJ, et al
    LI-RADS v2018: how to appropriately use ancillary features in category adjustment from intermediate probability of malignancy (LR-3) to probably HCC (LR-4) on gadoxetic acid-enhanced MRI.
    Eur Radiol. 2022;32:46-55.
    PubMed     Abstract available

    December 2021
  233. AUER TA, Fehrenbach U, Grieser C, Penzkofer T, et al
    Correction to: Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?
    Eur Radiol. 2021 Dec 5. pii: 10.1007/s00330-021-08386.

  234. GHANI MA, Fereydooni A, Chen E, Letzen B, et al
    Identifying enhancement-based staging markers on baseline MRI in patients with colorectal cancer liver metastases undergoing intra-arterial tumor therapy.
    Eur Radiol. 2021;31:8858-8867.
    PubMed     Abstract available

  235. LI M, Yang H, Liu Y, Zhang L, et al
    Comparison of the diagnostic performance of 2D and 3D MR elastography in staging liver fibrosis.
    Eur Radiol. 2021;31:9468-9478.
    PubMed     Abstract available

  236. YIN Y, Yakar D, Dierckx RAJO, Mouridsen KB, et al
    Liver fibrosis staging by deep learning: a visual-based explanation of diagnostic decisions of the model.
    Eur Radiol. 2021;31:9620-9627.
    PubMed     Abstract available

  237. SCHEGERER AA, Frija G, Paulo G, Jaschke W, et al
    Radiation dose and diagnostic reference levels for four interventional radiology procedures: results of the prospective European multicenter survey EUCLID.
    Eur Radiol. 2021;31:9346-9360.
    PubMed     Abstract available

    November 2021
  238. GRIESER C
    Editorial comment: advances in the evaluation of liver imaging and function with gadoxetic acid-enhanced MRI.
    Eur Radiol. 2021;31:8374-8375.

  239. MARKICH R, Palussiere J, Catena V, Cazayus M, et al
    Radiomics complements clinical, radiological, and technical features to assess local control of colorectal cancer lung metastases treated with radiofrequency ablation.
    Eur Radiol. 2021;31:8302-8314.
    PubMed     Abstract available

  240. QU Y, Middleton MS, Loomba R, Glaser KJ, et al
    Magnetic resonance elastography biomarkers for detection of histologic alterations in nonalcoholic fatty liver disease in the absence of fibrosis.
    Eur Radiol. 2021;31:8408-8419.
    PubMed     Abstract available

  241. FAN W, Guo J, Zhu B, Wang S, et al
    Drug-eluting beads TACE is safe and non-inferior to conventional TACE in HCC patients with TIPS.
    Eur Radiol. 2021;31:8291-8301.
    PubMed     Abstract available

  242. HAM JH, Yu JS, Choi JM, Cho ES, et al
    Corona enhancement can substitute enhancing capsule in the imaging diagnosis of small (
    Eur Radiol. 2021;31:8628-8637.
    PubMed     Abstract available

  243. LU X, Zhou H, Wang K, Jin J, et al
    Comparing radiomics models with different inputs for accurate diagnosis of significant fibrosis in chronic liver disease.
    Eur Radiol. 2021;31:8743-8754.
    PubMed     Abstract available

    October 2021
  244. YANG J, Huang JY, Chen X, Ling WW, et al
    Correction to: Combined hepatocellular-cholangiocarcinoma: can we use contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) to predict the patient's survival?
    Eur Radiol. 2021 Oct 14. pii: 10.1007/s00330-021-08256.

  245. BARGELLINI I, Lorenzoni V, Lorenzoni G, Scalise P, et al
    Duration of response after DEB-TACE compared to lipiodol-TACE in HCC-naive patients: a propensity score matching analysis.
    Eur Radiol. 2021;31:7512-7522.
    PubMed     Abstract available

  246. KONG C, Zhao Z, Chen W, Lv X, et al
    Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.
    Eur Radiol. 2021;31:7500-7511.
    PubMed     Abstract available

  247. RONG D, Liu W, Kuang S, Xie S, et al
    Preoperative prediction of pathologic grade of HCC on gadobenate dimeglumine-enhanced dynamic MRI.
    Eur Radiol. 2021;31:7584-7593.
    PubMed     Abstract available

  248. GUPTA P, Bansal A, Das GC, Kumar-M P, et al
    Diagnostic accuracy of Liver Imaging Reporting and Data System locoregional treatment response criteria: a systematic review and meta-analysis.
    Eur Radiol. 2021;31:7725-7733.
    PubMed     Abstract available

    September 2021
  249. CARBONELL G, Kennedy P, Bane O, Kirmani A, et al
    Precision of MRI radiomics features in the liver and hepatocellular carcinoma.
    Eur Radiol. 2021 Sep 26. pii: 10.1007/s00330-021-08282.
    PubMed     Abstract available

  250. JANG JK, Kim SY, Yoo IW, Cho YB, et al
    Diagnostic performance of ultrasound attenuation imaging for assessing low-grade hepatic steatosis.
    Eur Radiol. 2021 Sep 21. pii: 10.1007/s00330-021-08269.
    PubMed     Abstract available

  251. YU Y, Fan Y, Wang X, Zhu M, et al
    Gd-EOB-DTPA-enhanced MRI radiomics to predict vessels encapsulating tumor clusters (VETC) and patient prognosis in hepatocellular carcinoma.
    Eur Radiol. 2021 Sep 4. pii: 10.1007/s00330-021-08250.
    PubMed     Abstract available

  252. FRONDA M, Doriguzzi Breatta A, Gatti M, Calandri M, et al
    Quantitative assessment of HCC wash-out on CT is a predictor of early complete response to TACE.
    Eur Radiol. 2021;31:6578-6588.
    PubMed     Abstract available

  253. KANG JH, Choi SH, Lee JS, Kim KW, et al
    Inter-reader reliability of CT Liver Imaging Reporting and Data System according to imaging analysis methodology: a systematic review and meta-analysis.
    Eur Radiol. 2021;31:6856-6867.
    PubMed     Abstract available

  254. LI W, Li L, Zhuang BW, Ruan SM, et al
    Inter-reader agreement of CEUS LI-RADS among radiologists with different levels of experience.
    Eur Radiol. 2021;31:6758-6767.
    PubMed     Abstract available

  255. WANG G, Xie X, Chen H, Zhong Z, et al
    Development of a pediatric liver CEUS criterion to classify benign and malignant liver lesions in pediatric patients: a pilot study.
    Eur Radiol. 2021;31:6747-6757.
    PubMed     Abstract available

  256. GUPTA P, Maralakunte M, Sagar S, Kumar-M P, et al
    Efficacy and safety of irreversible electroporation for malignant liver tumors: a systematic review and meta-analysis.
    Eur Radiol. 2021;31:6511-6521.
    PubMed     Abstract available

  257. CANNELLA R, Fraum TJ, Ludwig DR, Borhani AA, et al
    Targetoid appearance on T2-weighted imaging and signs of tumor vascular involvement: diagnostic value for differentiating HCC from other primary liver carcinomas.
    Eur Radiol. 2021;31:6868-6878.
    PubMed     Abstract available

  258. LAIMER G, Jaschke N, Schullian P, Putzer D, et al
    Volumetric assessment of the periablational safety margin after thermal ablation of colorectal liver metastases.
    Eur Radiol. 2021;31:6489-6499.
    PubMed     Abstract available

    August 2021
  259. OCAL O, Peynircioglu B, Loewe C, van Delden O, et al
    Correlation of liver enhancement in gadoxetic acid-enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial.
    Eur Radiol. 2021 Aug 31. pii: 10.1007/s00330-021-08218.
    PubMed     Abstract available

  260. CHEN J, Allen AM, Therneau TM, Chen J, et al
    Liver stiffness measurement by magnetic resonance elastography is not affected by hepatic steatosis.
    Eur Radiol. 2021 Aug 25. pii: 10.1007/s00330-021-08225.
    PubMed     Abstract available

  261. KIM GH, Kim PH, Kim JH, Kim PN, et al
    Thermal ablation in the treatment of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis.
    Eur Radiol. 2021 Aug 4. pii: 10.1007/s00330-021-08216.
    PubMed     Abstract available

  262. NAGAYAMA Y, Kato Y, Inoue T, Nakaura T, et al
    Liver fibrosis assessment with multiphasic dual-energy CT: diagnostic performance of iodine uptake parameters.
    Eur Radiol. 2021;31:5779-5790.
    PubMed     Abstract available

  263. YOH T, Perrot A, Beaufrere A, Hobeika C, et al
    Liver surface nodularity: a novel predictor of post-hepatectomy liver failure in patients with colorectal liver metastases following chemotherapy.
    Eur Radiol. 2021;31:5830-5839.
    PubMed     Abstract available

  264. KOH DM, Ba-Ssalamah A, Brancatelli G, Fananapazir G, et al
    Consensus report from the 9(th) International Forum for Liver Magnetic Resonance Imaging: applications of gadoxetic acid-enhanced imaging.
    Eur Radiol. 2021;31:5615-5628.
    PubMed     Abstract available

  265. CHENG MQ, Hu HT, Huang H, Pan JM, et al
    Pathological considerations of CEUS LI-RADS: correlation with fibrosis stage and tumour histological grade.
    Eur Radiol. 2021;31:5680-5688.
    PubMed     Abstract available

  266. ALI A, Ahle M, Bjornsson B, Sandstrom P, et al
    Portal vein embolization with N-butyl cyanoacrylate glue is superior to other materials: a systematic review and meta-analysis.
    Eur Radiol. 2021;31:5464-5478.
    PubMed     Abstract available

  267. LEE DH, Lee ES, Bae JS, Lee JY, et al
    2D shear wave elastography is better than transient elastography in predicting post-hepatectomy complication after resection.
    Eur Radiol. 2021;31:5802-5811.
    PubMed     Abstract available

  268. HABIBZADEH F, Habibzadeh P, Shakibafard A, Saidi F, et al
    Predicting the outcome of asymptomatic univesicular liver hydatids: diagnostic accuracy of unenhanced CT.
    Eur Radiol. 2021;31:5812-5817.
    PubMed     Abstract available

  269. LIU LH, Zhou GF, Lv H, Wang ZC, et al
    Identifying response in colorectal liver metastases treated with bevacizumab: development of RECIST by combining contrast-enhanced and diffusion-weighted MRI.
    Eur Radiol. 2021;31:5640-5649.
    PubMed     Abstract available

    July 2021
  270. ZHOU C, Wang Y, Ma L, Qian X, et al
    Combined hepatocellular carcinoma-cholangiocarcinoma: MRI features correlated with tumor biomarkers and prognosis.
    Eur Radiol. 2021 Jul 19. pii: 10.1007/s00330-021-08188.
    PubMed     Abstract available

  271. NAJAFI A, de Baere T, Purenne E, Bayar A, et al
    Risk factors for local tumor progression after RFA of pulmonary metastases: a matched case-control study.
    Eur Radiol. 2021;31:5361-5369.
    PubMed     Abstract available

  272. HASENSTAB K, Cunha GM, Ichikawa S, Dehkordy SF, et al
    CNN color-coded difference maps accurately display longitudinal changes in liver MRI-PDFF.
    Eur Radiol. 2021;31:5041-5049.
    PubMed     Abstract available

  273. HUANG M, Shen S, Cai H, Peng Z, et al
    Regional liver function analysis with gadoxetic acid-enhanced MRI and virtual hepatectomy: prediction of postoperative short-term outcomes for HCC.
    Eur Radiol. 2021;31:4720-4730.
    PubMed     Abstract available

  274. MAO B, Ma J, Duan S, Xia Y, et al
    Preoperative classification of primary and metastatic liver cancer via machine learning-based ultrasound radiomics.
    Eur Radiol. 2021;31:4576-4586.
    PubMed     Abstract available

  275. PARK JH, Seo N, Chung YE, Kim SU, et al
    Noninvasive evaluation of liver fibrosis: comparison of the stretched exponential diffusion-weighted model to other diffusion-weighted MRI models and transient elastography.
    Eur Radiol. 2021;31:4813-4823.
    PubMed     Abstract available

  276. GUPTA P, Maralakunte M, Kumar-M P, Chandel K, et al
    Overall survival and local recurrence following RFA, MWA, and cryoablation of very early and early HCC: a systematic review and Bayesian network meta-analysis.
    Eur Radiol. 2021;31:5400-5408.
    PubMed     Abstract available

  277. YOUN SY, Kim DH, Choi SH, Kim B, et al
    Diagnostic performance of Liver Imaging Reporting and Data System treatment response algorithm: a systematic review and meta-analysis.
    Eur Radiol. 2021;31:4785-4793.
    PubMed     Abstract available

    June 2021
  278. YOON JH, Lee JM, Yu MH, Hur BY, et al
    Simultaneous evaluation of perfusion and morphology using GRASP MRI in hepatic fibrosis.
    Eur Radiol. 2021 Jun 12. pii: 10.1007/s00330-021-08087.
    PubMed     Abstract available

  279. VICENTIN I, Mosconi C, Garanzini E, Sposito C, et al
    Inter-center agreement of mRECIST in transplanted patients for hepatocellular carcinoma.
    Eur Radiol. 2021 Jun 12. pii: 10.1007/s00330-021-08088.
    PubMed     Abstract available

  280. OBMANN VC, Berzigotti A, Catucci D, Ebner L, et al
    T1 mapping of the liver and the spleen in patients with liver fibrosis-does normalization to the blood pool increase the predictive value?
    Eur Radiol. 2021;31:4308-4318.
    PubMed     Abstract available

  281. JIANG H, Song B, Qin Y, Chen J, et al
    Diagnosis of LI-RADS M lesions on gadoxetate-enhanced MRI: identifying cholangiocarcinoma-containing tumor with serum markers and imaging features.
    Eur Radiol. 2021;31:3638-3648.
    PubMed     Abstract available

  282. MIN JH, Kim SH, Hwang JA, Hyun SH, et al
    Prognostic value of LI-RADS category on gadoxetic acid-enhanced MRI and 18F-FDG PET-CT in patients with primary liver carcinomas.
    Eur Radiol. 2021;31:3649-3660.
    PubMed     Abstract available

  283. HECTORS SJ, Kennedy P, Huang KH, Stocker D, et al
    Fully automated prediction of liver fibrosis using deep learning analysis of gadoxetic acid-enhanced MRI.
    Eur Radiol. 2021;31:3805-3814.
    PubMed     Abstract available

    May 2021
  284. STOCKER D, Hectors S, Bane O, Vietti-Violi N, et al
    Dynamic contrast-enhanced MRI perfusion quantification in hepatocellular carcinoma: comparison of gadoxetate disodium and gadobenate dimeglumine.
    Eur Radiol. 2021 May 27. pii: 10.1007/s00330-021-08068.
    PubMed     Abstract available

  285. CHOI SH, Jeon SK, Lee SS, Lee JM, et al
    Radio-pathologic correlation of biphenotypic primary liver cancer (combined hepatocellular cholangiocarcinoma): changes in the 2019 WHO classification and impact on LI-RADS classification at liver MRI.
    Eur Radiol. 2021 May 26. pii: 10.1007/s00330-021-07984.
    PubMed     Abstract available

  286. KIM PH, Hwang J, Yoon HM, Shin HJ, et al
    Outcome of staging chest CT and identification of factors associated with lung metastasis in children with hepatoblastoma.
    Eur Radiol. 2021 May 25. pii: 10.1007/s00330-021-08047.
    PubMed     Abstract available

  287. NOWAK S, Mesropyan N, Faron A, Block W, et al
    Detection of liver cirrhosis in standard T2-weighted MRI using deep transfer learning.
    Eur Radiol. 2021 May 11. pii: 10.1007/s00330-021-07858.
    PubMed     Abstract available

  288. BAE H, Lee H, Kim S, Han K, et al
    Radiomics analysis of contrast-enhanced CT for classification of hepatic focal lesions in colorectal cancer patients: its limitations compared to radiologists.
    Eur Radiol. 2021 May 10. pii: 10.1007/s00330-021-07877.
    PubMed     Abstract available

  289. REIMER RP, Grosse Hokamp N, Fehrmann Efferoth A, Krauskopf A, et al
    Virtual monoenergetic images from spectral detector computed tomography facilitate washout assessment in arterially hyper-enhancing liver lesions.
    Eur Radiol. 2021;31:3468-3477.
    PubMed     Abstract available

  290. SCHULLIAN P, Johnston E, Laimer G, Putzer D, et al
    Frequency and risk factors for major complications after stereotactic radiofrequency ablation of liver tumors in 1235 ablation sessions: a 15-year experience.
    Eur Radiol. 2021;31:3042-3052.
    PubMed     Abstract available

  291. SAVIC LJ, Chapiro J, Funai E, Bousabarah K, et al
    Prospective study of Lipiodol distribution as an imaging marker for doxorubicin pharmacokinetics during conventional transarterial chemoembolization of liver malignancies.
    Eur Radiol. 2021;31:3002-3014.
    PubMed     Abstract available

    April 2021
  292. LIN CC, Lui KW, Chen WT, Hsieh YC, et al
    Switching monopolar radiofrequency ablation improves long-term outcomes of medium-sized hepatocellular carcinoma.
    Eur Radiol. 2021 Apr 25. pii: 10.1007/s00330-021-07729.
    PubMed     Abstract available

  293. PARK HJ, Park B, Park SY, Choi SH, et al
    Preoperative prediction of postsurgical outcomes in mass-forming intrahepatic cholangiocarcinoma based on clinical, radiologic, and radiomics features.
    Eur Radiol. 2021 Apr 23. pii: 10.1007/s00330-021-07926.
    PubMed     Abstract available

  294. LEE HJ, Hong SB, Lee NK, Kim S, et al
    Validation of functional liver imaging scores (FLIS) derived from gadoxetic acid-enhanced MRI in patients with chronic liver disease and liver cirrhosis: the relationship between Child-Pugh score and FLIS.
    Eur Radiol. 2021 Apr 21. pii: 10.1007/s00330-021-07955.
    PubMed     Abstract available

  295. RYU H, Shin SY, Lee JY, Lee KM, et al
    Joint segmentation and classification of hepatic lesions in ultrasound images using deep learning.
    Eur Radiol. 2021 Apr 21. pii: 10.1007/s00330-021-07850.
    PubMed     Abstract available

  296. TANG M, Zhou Q, Huang M, Sun K, et al
    Nomogram development and validation to predict hepatocellular carcinoma tumor behavior by preoperative gadoxetic acid-enhanced MRI.
    Eur Radiol. 2021 Apr 20. pii: 10.1007/s00330-021-07941.
    PubMed     Abstract available

  297. CUNHA GM, Hasenstab KA, Delgado T, Ichikawa S, et al
    Multi-arterial phase MRI depicts inconsistent arterial phase hyperenhancement (APHE) subtypes in liver observations of patients at risk for hepatocellular carcinoma.
    Eur Radiol. 2021 Apr 19. pii: 10.1007/s00330-021-07924.
    PubMed     Abstract available

  298. CHEN J, Xia C, Duan T, Cao L, et al
    Macrotrabecular-massive hepatocellular carcinoma: imaging identification and prediction based on gadoxetic acid-enhanced magnetic resonance imaging.
    Eur Radiol. 2021 Apr 15. pii: 10.1007/s00330-021-07898.
    PubMed     Abstract available

  299. HWANG JA, Min JH, Kang TW, Jeong WK, et al
    Assessment of factors affecting washout appearance of hepatocellular carcinoma on CT.
    Eur Radiol. 2021 Apr 15. pii: 10.1007/s00330-021-07897.
    PubMed     Abstract available

  300. STROBEL D, Jung EM, Ziesch M, Praktiknjo M, et al
    Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS(R)/ESCULAP) in hepatic nodules in cirrhotic patients-a prospective multicenter study.
    Eur Radiol. 2021 Apr 15. pii: 10.1007/s00330-021-07872.
    PubMed     Abstract available

  301. GHORRA C, Pommier R, Piveteau A, Rubbia-Brandt L, et al
    The diagnostic performance of a simulated "short" gadoxetic acid-enhanced MRI protocol is similar to that of a conventional protocol for the detection of colorectal liver metastases.
    Eur Radiol. 2021;31:2451-2460.
    PubMed     Abstract available

    Interventional radiology for liver diseases.
    Eur Radiol. 2021;31:2227-2230.

  303. KIM DH, Choi SH, Park SH, Kim KW, et al
    The Liver Imaging Reporting and Data System tumor-in-vein category: a systematic review and meta-analysis.
    Eur Radiol. 2021;31:2497-2506.
    PubMed     Abstract available

  304. VOGL TJ, Marko C, Langenbach MC, Naguib NNN, et al
    Transarterial chemoembolization of colorectal cancer liver metastasis: improved tumor response by DSM-TACE versus conventional TACE, a prospective, randomized, single-center trial.
    Eur Radiol. 2021;31:2242-2251.
    PubMed     Abstract available

    March 2021
  305. RONOT M, Ferraioli G, Muller HP, Friedrich-Rust M, et al
    Comparison of liver stiffness measurements by a 2D-shear wave technique and transient elastography: results from a European prospective multi-centre study.
    Eur Radiol. 2021;31:1578-1587.
    PubMed     Abstract available

  306. SARWAR A, Kudla A, Weinstein JL, Ali A, et al
    Yttrium-90 radioembolization using MIRD dosimetry with resin microspheres.
    Eur Radiol. 2021;31:1316-1324.
    PubMed     Abstract available

  307. XU X, Zhu H, Li R, Lin H, et al
    Whole-liver histogram and texture analysis on T1 maps improves the risk stratification of advanced fibrosis in NAFLD.
    Eur Radiol. 2021;31:1748-1759.
    PubMed     Abstract available

  308. SHAGHAGHI M, Aliyari Ghasabeh M, Ameli S, Ghadimi M, et al
    Post-TACE changes in ADC histogram predict overall and transplant-free survival in patients with well-defined HCC: a retrospective cohort with up to 10 years follow-up.
    Eur Radiol. 2021;31:1378-1390.
    PubMed     Abstract available

  309. LEFEBVRE T, Hebert M, Bilodeau L, Sebastiani G, et al
    Intravoxel incoherent motion diffusion-weighted MRI for the characterization of inflammation in chronic liver disease.
    Eur Radiol. 2021;31:1347-1358.
    PubMed     Abstract available

  310. COLAGRANDE S, Calistri L, Campani C, Dragoni G, et al
    CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenib.
    Eur Radiol. 2021;31:1608-1619.
    PubMed     Abstract available

    February 2021
  311. LEE S, Kim SS, Bae H, Shin J, et al
    Application of Liver Imaging Reporting and Data System version 2018 ancillary features to upgrade from LR-4 to LR-5 on gadoxetic acid-enhanced MRI.
    Eur Radiol. 2021;31:855-863.
    PubMed     Abstract available

  312. DING J, Long L, Zhang X, Chen C, et al
    Contrast-enhanced ultrasound LI-RADS 2017: comparison with CT/MRI LI-RADS.
    Eur Radiol. 2021;31:847-854.
    PubMed     Abstract available

    January 2021
  313. ALSHEHRI E, Lam CZ, Kamath BM, Chavhan GB, et al
    Abdominal lymphatic system visibility, morphology, and abnormalities in children as seen on routine MCRP and its association with immune-mediated diseases.
    Eur Radiol. 2021;31:292-301.
    PubMed     Abstract available

  314. GU K, Jeon TY, Yoo SY, Kim JH, et al
    Gd-EOB-DTPA MRI for focal nodular hyperplasia-like lesions in pediatric cancer survivors.
    Eur Radiol. 2021;31:283-291.
    PubMed     Abstract available

  315. SEO N, Jeong HK, Choi JY, Park MS, et al
    Liver MRI with amide proton transfer imaging: feasibility and accuracy for the characterization of focal liver lesions.
    Eur Radiol. 2021;31:222-231.
    PubMed     Abstract available

  316. STEINKOHL F, Barbieri F, Senoner T, Strobl S, et al
    Coronary atherosclerosis profile in patients with end-stage liver disease prior to liver transplantation due to alcoholic fatty liver: a coronary CTA study.
    Eur Radiol. 2021;31:494-503.
    PubMed     Abstract available

  317. TSAUO J, Noh SY, Shin JH, Gwon DI, et al
    Retrograde transvenous obliteration for the prevention of variceal rebleeding in patients with portal vein thrombosis: a multicenter study.
    Eur Radiol. 2021;31:559-566.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.